Clinical implications of circulating cell-free DNA quantification and metabolic tumor burden in advanced non-small cell lung cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Lung cancer"
DOI: 10.1016/j.lungcan.2019.06.014
Abstract: OBJECTIVES This study unravels the significance of cell-free DNA (cfDNA) quantification as a promising measure of the biological behavior/aggressiveness of tumors. Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) measured by positron emission tomography/computed… read more here.
Keywords: cfdna; tumor burden; cell; cfdna levels ... See more keywords
Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism
Sign Up to like & getrecommendations! Published in 2022 at "Thrombosis and Haemostasis"
DOI: 10.1055/s-0043-1760844
Abstract: Venous thromboembolism (VTE) is a common disease with high heritability. However, only a small portion of the genetic variance of VTE can be explained by known genetic risk factors. Neutrophil extracellular traps (NETs) have been… read more here.
Keywords: cfdna levels; cell free; cfdna; plasma cell ... See more keywords
Circulating extracellular DNA levels are acutely elevated in ischaemic stroke and associated with innate immune system activation
Sign Up to like & getrecommendations! Published in 2017 at "Brain Injury"
DOI: 10.1080/02699052.2017.1312018
Abstract: ABSTRACT Objective: The objective of this work was to assess the ability of peripheral blood cell-free DNA (cfDNA) levels to identify ischaemic stroke early in the acute phase of care, as well as to examine… read more here.
Keywords: cfdna levels; peripheral blood; blood; ischaemic stroke ... See more keywords
Assessment of dd-cfDNA Levels in Clinically Stable Lung Allograft Recipients Beyond the Initial 2 y Posttransplant
Sign Up to like & getrecommendations! Published in 2022 at "Transplantation Direct"
DOI: 10.1097/txd.0000000000001411
Abstract: Background. Donor-derived cell-free DNA (dd-cfDNA) is a useful biomarker for the diagnosis of acute allograft injury within the first 1 to 2 y after lung transplant, but its utility for diagnosing chronic lung allograft dysfunction… read more here.
Keywords: cfdna levels; clinically stable; cfdna; lung ... See more keywords
Admission Circulating Cell-Free DNA Levels as a Prognostic Factor in Pediatric Burns
Sign Up to like & getrecommendations! Published in 2022 at "BioMed Research International"
DOI: 10.1155/2022/5004282
Abstract: Background Burn injuries in children are a major physical and psychological trauma, often a severe condition with long-term consequences. Current methods of assessing the extent of burn injuries on admission are inaccurate. Circulating cell-free DNA… read more here.
Keywords: cfdna levels; pediatric burn; cfdna; circulating cell ... See more keywords
Endotheliopathy is associated with higher levels of cell-free DNA following major trauma: A prospective observational study
Sign Up to like & getrecommendations! Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0189870
Abstract: Background Cell free deoxyribonucleic acid (cfDNA) has been proposed as a biomarker of secondary complications following trauma. Raised thrombomodulin and syndecan-1 levels have been used to indicate endotheliopathy, and are associated with inflammation, coagulopathy, and… read more here.
Keywords: cfdna levels; cell free; trauma; cfdna ... See more keywords